[1]梁雄勇 张宝鉴 孙润芳 薛为民△ 赵聚峰 潘星源 刘建雄 刘俊.依降钙素联合归甲止痛胶囊治疗退变性腰椎管狭窄症的临床观察[J].中国中医骨伤科杂志,2018,26(05):10-13,18.
 LIANG Xiongyong ZHANG Baojian SUN Runfang XUE Weimin ZHAO Jufeng PAN Xingyuan LIU Jianxiong LIU Jun.Clinical Observation of Calcitonin Combined with Guijia Zhitong Capsule for Treating Degenerative Lumbar Spinal Stenosis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2018,26(05):10-13,18.
点击复制

依降钙素联合归甲止痛胶囊治疗退变性腰椎管狭窄症的临床观察()
分享到:

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第26卷
期数:
2018年05期
页码:
10-13,18
栏目:
临床研究
出版日期:
2018-05-02

文章信息/Info

Title:
Clinical Observation of Calcitonin Combined with Guijia Zhitong Capsule for Treating Degenerative Lumbar Spinal Stenosis
文章编号:
1005-0205(2018)05-0010-04
作者:
梁雄勇1 张宝鉴1 孙润芳1 薛为民1△ 赵聚峰1 潘星源1 刘建雄1 刘俊2
1山西省中医院脊柱外科(太原,030012) 2山西中医药大学中医系
Author(s):
LIANG Xiongyong1 ZHANG Baojian1 SUN Runfang1 XUE Weimin1△ ZHAO Jufeng1 PAN Xingyuan1 LIU Jianxiong1 LIU Jun2
1Shanxi Provincial Hospital of Traditional Chinese Medicine,Taiyuan 030012,China; 2Shanxi University of Traditional Chinese Medicine,Taiyuan 030024,China.
关键词:
依降钙素 归甲止痛胶囊 退变性腰椎管狭窄症
Keywords:
Keywords: calcitonin Guijia Zhitong capsule degenerative lumbar spinal stenosis
分类号:
R681.5
文献标志码:
A
摘要:
目的:观察依降钙素联合归甲止痛胶囊治疗退变性腰椎管狭窄症的有效性和安全性。方法:将2016年4月至2017年9月本科就诊的退变性腰椎管狭窄症患者按就诊顺序随机分为两组:观察组(38例)予依降钙素肌注并配合本院制剂归甲止痛胶囊口服; 对照组(38例)单纯予以依降钙素肌注。对所有患者均进行40 d的随访。采用视觉模拟疼痛评分(Visual Analogue Scale,VAS)、行走时被迫下蹲或休息时间、夜间睡眠时间、日本骨科学会评分(Japanese Orthopaedic Association,JOA)对纳入患者进行评估。定期对患者进行随访,记录相关测量数据。结果:两组患者治疗20 d后腰腿痛、行走时被迫下蹲或休息时间均改善,但对照组治疗20 d和40 d后VAS评分、行走时被迫下蹲或休息时间均大于观察组,差异有统计学意义(P<0.05); 两组患者治疗10 d后夜间睡眠时间均延长,但对照组治疗10,20及40 d后夜间睡眠时间均短于观察组,差异有统计学意义(P<0.05); 两组患者治疗10 d后JOA评分改善指数、改善率均提高,但对照组治疗10,20及40 d后JOA评分改善指数、改善率均低于观察组,差异有统计学意义(P<0.05)。结论:退变性腰椎管狭窄症给予依降钙素联合归甲止痛胶囊可减轻因退变性腰椎管狭窄导致的腰腿痛及功能障碍,并能有效延长夜间睡眠时间。
Abstract:
Abstract Objective:To observe the efficacy and safety of calcitonin combined with Guijia Zhitong capsule in the treatment of degenerative lumbar spinal stenosis.Methods:The patients with degenerative lumbar spinal stenosis treated from April 2016 to September 2017 were randomly divided into two groups.The observation group(n=38)was given calcitonin intramuscular injection combined with Guijia Zhitong capsule,and the control group(n=38)was simply administered with calcitonin intramuscular injection only,all patients were followed up for 40 days.The visual analogue scale(VAS),walking was forced to squat or rest time,sleep time during the night and the Japanese Orthopedic Association(JOA)were used to evaluate the effect.Patients were followed up on a regular basis,and the relevant measurement data was recorded.Results:Two groups of patients with waist and leg pain after 20 days of treatment,walking was forced to squat or rest time were improved.But the VAS score,walking was forced to squat or rest time in the control group were greater improved than the observation group at 20,40 days after treatment(P<0.05).The sleep time during the night was prolonged in both groups 10 days after treatment,but sleep time during the night in the control group was shorter than that in the observation group 10,20 and 40 days after treatment(P<0.05).The JOA score were improved in both groups 10 days after treatment,but the JOA score in the control group were improved lower than those in the observation group(P<0.05).Conclusion:The calcitonin combined with Guijia Zhitong capsules is effective for degenerative lumbar spinal stenosis,which can reduce waist and leg pain,improve oswestry disability,and can effectively extend the sleep time during the night.

参考文献/References:

[1] 中华医学会.临床诊疗常规:骨科学分册[M].北京:人民卫生出版社,2009.
[2] 周春,李新锋.腰椎间孔内镜治疗高龄腰椎管狭窄症短期疗效的初步研究[J].中华骨与关节外科杂志,2017,10(2):95-99.
[3] Porter RW,Hibbert C.Calcitonin treatment for neurogenic claudication[J].Spine(Phila Pa 1976),1983,8(6):585-592.
[4] Kanchiku T,Imajo K,Suzuki H,et al.Comparisons on efficacy of elcatonin and limaprost alfadex in patients with lumbar spinal stenosis and concurrent osteoporosis:a preliminary study using a crossover design[J].Asian Spine J,2014,8(4):469-475.
[5] Haddadi K,Asadian L,Isazade A.Effects of nasal calcitonin vs.Oral gabapentin on pain and symptoms of lumbar spinal stenosis:a clinical trial study[J].Clin Med Insights Arthritis Musculoskelet Disord,2016,9:133-138.
[6] 李杰.骨质疏松症与腰椎管狭窄症的相关性分析[D].济南:山东中医药大学,2001.
[7] 张楠,张柳.降钙素对骨性关节炎中软骨作用的研究进展[J].中国矫形外科杂志,2007,15(13):987-988.
[8] 张楠,张柳,郑桓,等.降钙素在体内和体外实验中对兔关节炎关节软骨的保护作用[J].中国矫形外科杂志,2008,16(1):66-69.
[9] 李任增,张柳,高晓增.降钙素对兔骨关节炎关节软骨的保护作用[J].中国矫形外科杂志,2006,14(2):121-123.
[10] 蓝旭,高杰,许建中,等.腰椎黄韧带骨化伴腰椎管狭窄的治疗[J].中国骨伤,2017,30(2):175-178.
[11] Luo Y,Zhang L,Wang WY,et al.The inhibitory effect of salmon calcitonin on intervertebral disc degeneration in anovariectomized rat model[J].Eur Spine J,2015,24(8):1691-1701.
[12] Liu CC,Tian FM,Zhou Z,et al.Protective effect of calcitonin on lumbar fusion-induced adjacent-segment disc degeneration in ovariectomized rat[J].BMC Musculoskelet Disord,2015,16:342.
[13] Jiang X,Tian F,Wang W,et al.Effect of calcitonin pretreatment on naturally occurring intervertebral disc degeneration in guinea pig[J].Int J Clin Exp Med,2015,8(7):10367-10379.
[14] Ito A,Kumamoto E,Takeda M,et al.Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin:participation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord[J].J Neurosci,2000,20(16):6302-6308.
[15] Schou WS,Ashina S,Amin FM,et al.Calcitonin gene-related peptide and pain:a systematic review[J].J Headache Pain,2017,18(1):34.
[16] Cho HK,Sang HA,Kim SY,et al.Changes in the expressions of iba1 and calcitonin gene-related peptide in adjacent lumbar spinal segments after lumbar disc herniation in a rat model[J].J Korean Med Sci,2015,30(12):1902-1910.
[17] 史少岩,黄研生,郝定均.腰椎管狭窄的治疗进展[J].中国骨伤,2017,30(5):484-488.
[18] 林晓毅,林凤晖.两种术式治疗腰椎管狭窄症的临床疗效比较[J].中国中医骨伤科杂志,2015,23(8):33-36.
[19] Peng K,Chen L,Peng J,et al.Effects of calcitonin on lumbar spinal stenosis:a systematic review and meta-analysis[J].International Journal of Clinical and Experimental Medicine,2015,8(2):2536-2544.

备注/Memo

备注/Memo:
基金项目:山西省中医药研究院院级课题(2016ZJ01) 通信作者 E-mail:lc325007@163.com
更新日期/Last Update: 2018-05-02